Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology
about
Moxibustion for cancer care: a systematic review and meta-analysisThe use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive studyReiki and related therapies in the dialysis ward: an evidence-based and ethical discussion to debate if these complementary and alternative medicines are welcomed or bannedChinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancerHigh-dose vitamin C therapy: renewed hope or false promise?Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancerWhy bortezomib cannot go with 'green'?Use of complementary/alternative therapies by women with advanced-stage breast cancerEfficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-AnalysisMapping the risk perception and communication gap between different professions of healthcare providers in cancer care: a cross-sectional protocolPersonal prayer in patients dealing with chronic illness: a review of the research literatureNutritional status in relation to treatment modalitiesNutraceutical use in late-stage cancer.Potential health risks of complementary alternative medicines in cancer patientsDeveloping a molecular roadmap of drug-food interactionsIdentifying unproven cancer treatments on the health web: addressing accuracy, generalizability and scalabilityThreat posed by unproven drugs in medical oncologyNaturopathic Oncology Modified Delphi Panel.Modulation of experimental atopic dermatitis by topical application of Gami-Cheongyeul-Sodok-Eum.Use of selected complementary and alternative medicine (CAM) treatments in veterans with cancer or chronic pain: a cross-sectional survey.Qigong for cancer treatment: a systematic review of controlled clinical trials.Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancerPhysician and patient attitudes towards complementary and alternative medicine in obstetrics and gynecology.Understanding, beliefs and perspectives of Aboriginal people in Western Australia about cancer and its impact on access to cancer services.Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey.Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.Alternative therapy and abnormal liver function during adjuvant chemotherapy in breast cancer patients.Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials.HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.Soliciting an herbal medicine and supplement use history at hospice admissionTesticular morphology of male rats exposed to Phaleria macrocarpa (Mahkota dewa) aqueous extractA pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkersUnderstanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors.Spiritual Therapy in Coping with Cancer as a Complementary Medical Preventive Practice.Methodological issues in trials of complementary and alternative medicine interventions.Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionalsThe roles of herbal remedies in survival and quality of life among long-term breast cancer survivors--results of a prospective study.Gypenosides suppress growth of human oral cancer SAS cells in vitro and in a murine xenograft model: the role of apoptosis mediated by caspase-dependent and caspase-independent pathways.
P2860
Q21093313-0E39CB68-16A8-4371-8146-FE5EB0D3EF6BQ21260415-85084E74-A092-4EB1-AB21-1FF1EE6D6F27Q21261420-492F8549-F6CB-420E-9A0C-507C16CB5F40Q24201014-56E2BA8F-9793-4D6E-9E86-8955C65A782EQ24540522-2F936E72-BBBC-47FB-BDE8-982F847D058EQ24628786-64C1A8F9-7D81-41E0-A4DF-F2D8AF3CB63AQ24630709-6F85304A-85C3-456C-9F73-BE1DF144421DQ24799982-CA2B4CD6-BF05-46AE-BFD0-4E1AEF37291DQ26778653-2E8EBA47-C7A1-466E-B192-96201B5459B4Q26785616-139C209D-0C06-44D7-B2B1-C170BDF756B8Q27022639-5F9ADE99-B5A6-4C90-AA5D-27C1DDA8F7E6Q27027294-8010FE20-D747-4E49-B305-6FB81591FF3DQ27693359-F93929CF-4734-4E30-8E00-48DBC03CF098Q28166863-9BDAFA46-EE00-43EF-B73A-4FFCA400A918Q28543374-65509418-F124-4C6B-995F-AB29E31A75B5Q28655814-5BE600CB-91D1-4E95-8C64-437F33515A33Q29303933-E9B6A268-611B-4567-BCBB-83BBEE6313F0Q30377155-0B9E49C3-BB59-4D40-8447-B10DE90592E1Q31150416-F62B8E82-7670-4709-9977-05C89B65061DQ33259662-96E72C06-44D1-4069-A57C-7606B54A8133Q33291814-D9ED5E23-2732-4467-A9FA-070E5F224B45Q33298686-D5BC29CB-0E36-4999-BD72-950ED5015827Q33304238-B1E9D63F-325D-4E06-BD89-6B7545216B58Q33346980-F1562546-A94F-43C1-9324-FC6D842C9B3DQ33488726-C7FDCF46-2CE5-4706-AE54-A1993A372113Q33587343-611600B5-6070-4DC0-BA09-C9BECC44DF3AQ33610851-D56372A3-3348-4F93-9C13-CD939E905F7EQ33631568-FF32B6BD-F11B-4DD7-A433-61318B36975BQ33648514-C7ADF1D9-E794-4E9D-B58B-5C385E640556Q33685487-82AC0062-D3CD-407B-91CE-465EC3D0BFF5Q33732930-8EDC56A6-647D-414E-AC5D-418A4DD5C4A6Q33751861-69ADEF32-FE64-4EB5-A518-9C7760F6AA73Q33802580-72BB1098-D187-4BDF-AF54-6C82DAABAD2CQ33830320-45616789-F7A9-4AA6-800B-893B620CA2C1Q33886054-86673B28-3A4D-4BD5-A876-25D21A8CF2C9Q33888071-E97F8721-AC34-4D80-8061-11CE12D70C92Q33892540-292D3560-310F-4CD7-8AA0-2375B2E73929Q33910457-E787590A-8706-4743-A0CC-0F71ED9FB84DQ33924599-09368E8C-2CCD-4988-8B44-DB6D1E54B06DQ33930229-9CEE4490-8F07-4988-96EA-196497EAE872
P2860
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Complementary/alternative medi ...... the implications for oncology
@ast
Complementary/alternative medi ...... the implications for oncology
@en
Complementary/alternative medi ...... the implications for oncology
@nl
type
label
Complementary/alternative medi ...... the implications for oncology
@ast
Complementary/alternative medi ...... the implications for oncology
@en
Complementary/alternative medi ...... the implications for oncology
@nl
prefLabel
Complementary/alternative medi ...... the implications for oncology
@ast
Complementary/alternative medi ...... the implications for oncology
@en
Complementary/alternative medi ...... the implications for oncology
@nl
P2093
P3181
P1476
Complementary/alternative medi ...... the implications for oncology
@en
P2093
A Greisinger
J L Palmer
M A Richardson
S E Singletary
P304
P3181
P356
10.1200/JCO.2000.18.13.2505
P407
P577
2000-07-01T00:00:00Z